Updates on possible mitigation strategies to reduce the risk of nitrosamine drug substance-related impurities in drug products

[FDA]

The agency updated the guidance in February 2021 to specify timeframes for completion of nitrosamine mitigation activities by drug manufacturers.


Baca selengkapnya di : http://www.fda.gov...